Target intelligence / Profile preview

Peptide-major histocompatibility complex-T cell receptor interface

Molecular classification
Protein-protein interface, Immune synapse, Receptor-ligand interaction, Other
01

Overview

The **Peptide-major histocompatibility complex-T cell receptor (Peptide-MHC-TCR) interface** is the structural and functional contact zone where a T cell receptor (TCR) binds to a peptide presented by a major histocompatibility complex (MHC) molecule on an antigen-presenting cell[1][4][5]. This interaction is fundamental to the cellular arm of the adaptive immune response, dictating the specificity and activation of T cells. The interface comprises three main components—the peptide (usually 8–15 amino acids long), the MHC molecule (often highly polymorphic), and the TCR itself (formed by variable α/β chains)[5]. Structural studies show that the TCR typically recognizes the antigenic peptide by using its hypervariable complementarity-determining region 3 (CDR3) loops, while the CDR1 and CDR2 loops primarily interact with the MHC molecule[1][4]. The docking geometry and conformational changes at the interface are critical for antigen specificity and avoidance of off-target or autoimmune responses[1][3][4][5]. Extensive structural variability and flexibility at this site allow recognition of diverse peptide antigens, but also pose challenges for predicting specificity and engineering safe therapeutics[1][2][6]. The Peptide-MHC-TCR interface is an active target in immunotherapy, including TCR-engineered cell therapies, peptide-MHC vaccines, and structural-based drug design aiming to manipulate immune recognition or tolerance[4][5][6]. Safety concerns largely stem from the potential to trigger undesirable immune reactions due to cross-reactivity or loss of TCR specificity, underscoring the need for robust structure-guided approaches in clinical applications[4][6].

Other names
TCR:pMHC interfaceT cell receptor-peptide-MHC interfaceT cell receptor:peptide-MHC interfaceTCR-antigen-MHC interface
02

Mechanism of action

Modulation of antigen recognition specificity; Induction of T cell activation and cytotoxicity; Allosteric modulation of TCR-pMHC binding; Enhanced immune synapse formation

03

Biological functions

Antigen recognitionImmune responseT cell activationCell-mediated immunity
04

Disease associations

CancerInfectionAutoimmune diseaseOther
05

Safety considerations

Off-target T cell activationCytokine release syndromeAutoimmunity from cross-reactivityLoss of specificity (cross-reactivity to self-peptides)
06

Interacting drugs

Engineered T cell receptor therapeutics

3 more in the full profile.

07

Biomarkers

Specific TCR clonotypesPeptide-MHC tetramer positivityT cell activation markers (e.g., CD69, CD25)Cytokine release profiles (e.g., IFN-γ, IL-2)

Beyond the preview

Go deeper on Peptide-major histocompatibility complex-T cell receptor interface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptide-major histocompatibility complex-T cell receptor interface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call